About Cevec Pharmaceuticals
Cevec Pharmaceuticals is a company based in Koln (Germany) founded in 2001 was acquired by Cytiva in October 2022.. Cevec Pharmaceuticals has raised $28.43 million across 7 funding rounds from investors including Cytiva, NRW.Bank and Creathor Venture. The company has 39 employees as of December 31, 2020. Cevec Pharmaceuticals operates in a competitive market with competitors including Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others.
- Headquarter Koln, Germany
- Employees 39 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cevec Pharmaceuticals Gmbh
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Cevec Pharmaceuticals
Cevec Pharmaceuticals has successfully raised a total of $28.43M across 7 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Last Round
-
First Round
First Round
(03 Nov 2009)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Series E - Cevec Pharmaceuticals | Valuation |
investors |
|
| Apr, 2019 | Amount | Series D - Cevec Pharmaceuticals | Valuation |
investors |
|
| Jul, 2015 | Amount | Series C - Cevec Pharmaceuticals | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cevec Pharmaceuticals
Cevec Pharmaceuticals has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Cytiva, NRW.Bank and Creathor Venture. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital investments are made in life science innovations.
|
Founded Year | Domain | Location | |
|
Loans, advice, seminars, and networks are provided for financial support.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cevec Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cevec Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cevec Pharmaceuticals Comparisons
Competitors of Cevec Pharmaceuticals
Cevec Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, BridgeBio, ATAI, Forge Biologics and Spark Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| domain | founded_year | HQ Location |
Therapeutics for genetic diseases are developed through targeted interventions.
|
|
| domain | founded_year | HQ Location |
A biopharmaceutical company accelerating innovative mental health treatments.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases are developed to treat patients.
|
|
| domain | founded_year | HQ Location |
Gene therapies for rare diseases including retinal dystrophies are developed.
|
|
| domain | founded_year | HQ Location |
Provider of cell therapies to treat cancer and hematologic conditions
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cevec Pharmaceuticals
Frequently Asked Questions about Cevec Pharmaceuticals
When was Cevec Pharmaceuticals founded?
Cevec Pharmaceuticals was founded in 2001 and raised its 1st funding round 8 years after it was founded.
Where is Cevec Pharmaceuticals located?
Cevec Pharmaceuticals is headquartered in Koln, Germany. It is registered at Koln, North Rhine-westphalia, Germany.
Is Cevec Pharmaceuticals a funded company?
Cevec Pharmaceuticals is a funded company, having raised a total of $28.43M across 7 funding rounds to date. The company's 1st funding round was a Series C of $4.89M, raised on Nov 03, 2009.
How many employees does Cevec Pharmaceuticals have?
As of Dec 31, 2020, the latest employee count at Cevec Pharmaceuticals is 39.
What does Cevec Pharmaceuticals do?
Cevec Pharmaceuticals was founded in 2001 and is based in Cologne, Germany. Operations focus on the biotechnology sector, where glyco-optimized human suspension cell lines are developed for recombinant protein glycosylation through the CAP Go expression platform. Gene therapy vectors are produced using the scalable CAP GT system and ELEVECTA technology for AAV manufacturing. Cell line development and protein expression services are also offered to support research and production needs.
Who are the top competitors of Cevec Pharmaceuticals?
Cevec Pharmaceuticals's top competitors include Spark Therapeutics, BridgeBio and Forge Biologics.
Who are Cevec Pharmaceuticals's investors?
Cevec Pharmaceuticals has 6 investors. Key investors include Cytiva, NRW.Bank, Creathor Venture, Peppermint Venture Partners, and Midas Group.